TSS:Rfhg 34931.1

Basic information about the TSS

---

TSS ID: rfhg_34931.1 Species: human Chr: chr2		Start: 174223138 End: 174223138 Strand: -
Source datasets	PRJNA597322
Protocol	STRIPE-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF116703:59 GeneID: 29789 HGNC/MGI_ID: HGNC:28833 UniProt_ID: Nearer transcript ids and distances:

Gene_name: Obg like ATPase 1 Gene_symbol: OLA1 Gene_synonyms: PTD004 Gene_source: HGNC:28833

TATA-Box annotation

---

Distance to TSS:	25394
Nearest PromoterID:	NM_001328688
Entrez ID:	29789
Nearest Unigene:	Hs.157351
Nearest Refseq:	NM_013341
Nearest Ensembl:	ENSG00000138430
Gene Name:	Obg like ATPase 1
Gene Alias:	DOC45|GBP45|GTBP9|GTPBP9|PTD004
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OLA1 p2@OLA1 p3@OLA1
Sample		p1@OLA1	p2@OLA1	p3@OLA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.62	9.74	52.60
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.06	9.51	60.90
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.81	10.42	54.40
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.25	7.90	49.48
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.35	9.45	59.17
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.87	12.21	52.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	48.37	14.60	98.48
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.59	9.93	78.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.00	10.04	80.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	33.62	11.01	106.65
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	32.74	8.49	116.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	23.17	6.91	117.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	49.97	9.83	12.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	56.38	18.49	10.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	48.96	13.39	12.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	56.33	11.57	9.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	55.26	15.73	12.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	53.57	13.50	10.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	49.58	11.20	10.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	42.27	11.73	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	57.60	15.10	13.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	50.41	15.19	9.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	59.98	14.86	10.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	50.47	16.99	15.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.92	14.45	14.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.69	11.71	12.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	63.19	18.68	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	39.84	15.80	13.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	44.10	11.31	13.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	54.83	13.75	13.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	56.10	11.93	15.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.14	19.15	13.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	55.29	12.87	12.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	72.08	22.43	15.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	47.12	14.96	14.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.08	14.75	16.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	54.98	14.92	16.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	52.19	19.75	16.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	50.78	17.29	12.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.05	14.16	16.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	52.93	16.47	17.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	63.83	19.91	14.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.91	11.60	20.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	44.93	12.41	18.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.14	13.85	20.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.04	13.03	18.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	45.34	11.28	18.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	40.83	16.69	14.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	34.71	12.69	16.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.43	13.55	15.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.06	11.27	19.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	39.58	11.79	22.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	587.67	419.77	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	45.07	11.36	29.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.14	15.58	24.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	128.36	73.83	28.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	53.73	21.58	14.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.19	13.29	23.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.51	7.71	30.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	45.58	22.32	10.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	14.10	30.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	34.77	14.02	17.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	36.62	16.72	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	41.11	14.61	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.37	12.35	25.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.91	10.29	19.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	581.90	339.44	96.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	513.34	308.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.35	15.11	18.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	11.41	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.46	14.54	11.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	28.81	11.92	8.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	26.91	13.30	18.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	15.29	14.68
Adipocyte - breast, donor1	11376-118A8	36.27	14.25	4.28
Adipocyte - breast, donor2	11327-117E4	23.90	8.34	3.05
Adipocyte - omental, donor1	11473-119C6	35.24	16.03	3.56
Adipocyte - omental, donor2	11474-119C7	14.95	10.46	2.24
Adipocyte - omental, donor3	11475-119C8	18.09	8.37	5.02
Adipocyte - perirenal, donor1	11476-119C9	17.86	5.10	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	6.60	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	31.61	8.58	6.77
Adipocyte - subcutaneous, donor3	11408-118E4	53.00	15.12	7.82
Adipocyte differentiation, day04, donor1	13019-139D4	35.01	16.23	5.08
Adipocyte differentiation, day04, donor2	13022-139D7	11.84	7.46	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	23.97	10.87	5.30
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	9.99	3.53
Adipocyte differentiation, day08, donor1	13020-139D5	37.88	26.54	7.80
Adipocyte differentiation, day08, donor2	13023-139D8	21.30	7.42	2.90
Adipocyte differentiation, day08, donor3	13026-139E2	14.93	11.20	3.73
Adipocyte differentiation, day08, donor4	13029-139E5	27.82	10.57	3.90
Adipocyte differentiation, day12, donor1	13021-139D6	16.64	14.97	5.82
Adipocyte differentiation, day12, donor2	13024-139D9	14.57	5.27	3.01
Adipocyte differentiation, day12, donor3	13027-139E3	25.85	8.18	3.60
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	7.92	5.48
Alveolar Epithelial Cells, donor1	11510-119G7	29.83	10.17	11.93
Alveolar Epithelial Cells, donor2	11590-120G6	10.04	1.08	5.38
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	28.25	6.48	6.66
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	21.37	5.75	4.73
Anulus Pulposus Cell, donor1	11248-116E6	138.68	25.75	7.90
Anulus Pulposus Cell, donor2	11463-119B5	58.53	9.31	6.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	40.44	10.78	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	37.34	10.85	5.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	68.49	8.56	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.49	12.26	6.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	53.12	7.59	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	6.60	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	29.56	10.40	3.57
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	34.95	12.14	5.83
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	33.85	11.88	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	30.13	14.31	4.52
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.01	10.89	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	38.87	10.03	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	71.83	22.07	5.11
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	36.85	6.82	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.74	13.72	4.37
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	39.11	9.11	5.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	37.60	13.23	5.29
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	48.91	12.03	3.74
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	33.17	3.90	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.01	14.43	5.97
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	7.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.34	13.04	3.95
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	16.78	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.98	10.19	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.84	20.87	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	9.69	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.33	10.83	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	41.04	10.05	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	38.97	7.23	4.39
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	32.38	10.32	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	48.23	11.58	3.86
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	25.68	9.27	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	36.85	12.87	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	39.44	11.44	4.52
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	14.26	13.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	13.22	5.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.89	16.81	4.08
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.12	7.62	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	39.27	9.06	4.32
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	39.80	11.43	4.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.70	9.57	4.93
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	41.57	7.56	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	36.62	11.87	5.42
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	9.27	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	8.45	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	36.66	11.36	4.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.90	10.83	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	11.66	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	35.86	14.02	3.68
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	5.10	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.90	9.15	5.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.11	14.24	4.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.48	8.57	6.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.81	10.52	4.78
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.48	11.31	3.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	41.20	6.10	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	7.75	3.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.37	11.92	3.71
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.53	9.45	3.63
Astrocyte - cerebellum, donor1	11500-119F6	42.25	11.67	6.14
Astrocyte - cerebellum, donor2	11580-120F5	17.29	4.45	3.94
Astrocyte - cerebellum, donor3	11661-122F5	12.38	1.05	4.19
Astrocyte - cerebral cortex, donor1	11235-116D2	85.75	30.33	18.82
Astrocyte - cerebral cortex, donor2	11316-117D2	61.96	27.83	22.32
Astrocyte - cerebral cortex, donor3	11392-118C6	44.90	25.66	23.27
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	103.33	52.53	17.66
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	103.48	55.50	18.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	90.01	50.98	17.64
Basophils, donor1	12241-129G9	20.14	5.75	3.40
Basophils, donor2	12242-129H1	51.23	15.51	4.33
Basophils, donor3	12243-129H2	32.63	7.06	4.12
Bronchial Epithelial Cell, donor1	11511-119G8	35.57	7.76	3.88
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	1.37	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	21.52	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	32.64	11.30	15.06
Bronchial Epithelial Cell, donor5	11457-119A8	28.91	5.61	10.81
Bronchial Epithelial Cell, donor6	11461-119B3	64.71	12.21	23.72
Bronchial Epithelial Cell, donor7	11769-123I5	69.82	16.38	12.24
Burkitt's lymphoma cell line:DAUDI	10422-106C8	125.83	46.27	30.30
Burkitt's lymphoma cell line:RAJI	10476-106I8	193.78	62.19	30.98
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	118.64	46.37	14.39
CD133+ stem cells - cord blood derived, pool1	12223-129E9	206.84	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	56.36	6.76	5.07
CD14+ Monocytes, donor2	11305-117B9	32.11	7.24	4.83
CD14+ Monocytes, donor3	11381-118B4	22.39	6.37	5.93
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	43.31	15.57	5.94
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.80	10.99	6.82
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	43.72	17.09	3.29
CD14+ monocytes - mock treated, donor1	11863-125A9	27.90	4.34	4.05
CD14+ monocytes - mock treated, donor2	11873-125C1	21.12	3.62	4.53
CD14+ monocytes - mock treated, donor3	11883-125D2	18.71	4.03	4.50
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.58	1.84	3.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.84	1.66	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.88	4.21	3.47
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.38	2.94	2.35
CD14+ monocytes - treated with BCG, donor2	11870-125B7	20.48	3.56	5.70
CD14+ monocytes - treated with BCG, donor3	11880-125C8	39.61	5.88	6.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.48	3.98	6.56
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.10	4.22	4.22
CD14+ monocytes - treated with Candida, donor3	11888-125D7	24.41	3.33	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.22	4.76	3.12
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.96	3.79	5.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	23.53	6.25	5.20
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.68	2.52	4.35
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.26	3.62	2.94
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.04	4.80	4.80
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.83	2.96	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.18	5.58	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	25.25	2.52	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	19.47	2.39	4.41
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.15	3.52	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	3.07	7.02
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.54	3.66	4.53
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.04	4.46	3.72
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	44.19	7.98	4.31
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	19.25	2.87	5.32
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.95	4.17	5.10
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	19.49	6.26	5.34
CD14+CD16+ Monocytes, donor1	11789-124B7	53.40	13.30	5.45
CD14+CD16+ Monocytes, donor2	11801-124D1	56.13	10.63	5.54
CD14+CD16+ Monocytes, donor3	11912-125G4	46.36	13.65	8.23
CD14+CD16- Monocytes, donor1	11788-124B6	73.35	17.29	7.01
CD14+CD16- Monocytes, donor2	11799-124C8	71.60	14.50	6.11
CD14+CD16- Monocytes, donor3	11910-125G2	53.07	13.16	6.24
CD14-CD16+ Monocytes, donor1	11790-124B8	30.88	5.87	4.59
CD14-CD16+ Monocytes, donor2	11800-124C9	44.13	7.03	6.59
CD14-CD16+ Monocytes, donor3	11911-125G3	42.53	7.79	8.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	4.06	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	68.48	18.98	6.78
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	59.03	11.39	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	62.90	12.26	11.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	79.34	21.44	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	50.54	12.63	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	60.40	11.77	6.27
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	67.23	14.50	7.91
CD19+ B Cells, donor1	11544-120B5	29.59	7.40	9.04
CD19+ B Cells, donor2	11624-122B4	31.92	7.25	4.35
CD19+ B Cells, donor3	11705-123B4	33.32	8.58	6.56
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	65.05	35.15	40.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	49.94	22.37	30.76
CD34+ Progenitors, donor1	11545-120B6	63.26	19.08	11.04
CD34+ Progenitors, donor2	11625-122B5	111.80	20.79	10.67
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	101.45	48.10	15.78
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	119.96	47.35	15.78
CD4+ T Cells, donor1	11225-116C1	83.55	22.14	7.86
CD4+ T Cells, donor2	11306-117C1	42.25	11.02	4.90
CD4+ T Cells, donor3	11382-118B5	43.00	15.86	4.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.09	25.27	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	62.66	28.52	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	48.29	23.28	3.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	55.47	18.02	8.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	64.61	21.77	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	6.59	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	61.85	25.72	3.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.77	19.49	3.56
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.04	18.38	2.58
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	55.59	16.59	5.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	71.97	16.42	6.64
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	61.16	24.64	4.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.15	25.30	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.80	17.87	2.91
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.45	14.03	4.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	94.91	27.19	5.98
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	96.47	26.26	6.43
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	78.90	26.90	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.17	34.12	4.64
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	54.37	34.44	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.33	23.54	3.15
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	66.74	19.72	5.56
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	62.82	24.70	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	72.78	24.41	6.10
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	85.12	28.70	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	79.39	19.39	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	72.58	29.31	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	110.77	28.52	6.37
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	128.09	39.26	7.85
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	107.80	26.18	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	85.59	30.80	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	103.87	18.00	5.54
CD8+ T Cells, donor1	11226-116C2	59.91	23.90	6.55
CD8+ T Cells, donor2	11307-117C2	36.42	13.52	4.88
CD8+ T Cells, donor3	11383-118B6	43.18	14.14	7.07
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.12	10.32	8.49
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.58	11.98	7.43
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.43	16.42	5.47
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.21	20.41	6.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.88	12.00	7.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.01	12.96	4.32
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.81	19.99	8.04
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	17.11	19.48	7.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.04	19.70	5.39
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.04	19.32	6.04
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	25.85	17.14	7.55
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.52	19.45	7.19
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.20	11.38	8.76
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	9.11	8.65
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	5.97	9.70
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	13.33	13.33	10.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.40	14.96	5.47
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.86	12.73	6.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.11	27.25	6.97
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.15	18.45	11.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	19.88	16.99	6.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.12	21.42	7.65
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.86	17.73	9.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	29.50	12.10	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	23.29	16.06	10.44
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	10.49	11.89
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	20.04	16.03
Cardiac Myocyte, donor1	11525-119I4	42.04	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	37.55	19.27	8.40
Cardiac Myocyte, donor3	11686-122I3	56.30	26.83	8.94
Chondrocyte - de diff, donor1	11261-116G1	68.29	21.84	11.44
Chondrocyte - de diff, donor2	11338-117F6	29.14	3.91	3.91
Chondrocyte - de diff, donor3	11410-118E6	56.43	15.93	5.92
Chondrocyte - re diff, donor2	11339-117F7	53.72	25.96	8.95
Chondrocyte - re diff, donor3	11411-118E7	23.86	5.66	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	122.91	39.48	24.21
Ciliary Epithelial Cells, donor2	11323-117D9	56.01	19.03	17.96
Ciliary Epithelial Cells, donor3	11399-118D4	60.00	21.95	16.55
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.86	7.34	15.22
Corneal Epithelial Cells, donor1	11526-119I5	21.52	3.95	6.37
Corneal Epithelial Cells, donor2	11606-120I4	31.85	7.96	5.69
Corneal Epithelial Cells, donor3	11687-122I4	27.86	5.88	11.50
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	48.70	18.82	4.79
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	47.94	17.35	5.99
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	17.25	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	35.64	12.20	4.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	52.27	24.26	6.15
Dendritic Cells - plasmacytoid, donor2	11309-117C4	55.49	26.77	4.57
Dendritic Cells - plasmacytoid, donor3	11385-118B8	51.78	24.68	5.81
Endothelial Cells - Aortic, donor0	11207-116A1	57.70	22.18	5.84
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	11.74	8.80
Endothelial Cells - Aortic, donor2	11340-117F8	31.11	10.75	5.37
Endothelial Cells - Aortic, donor3	11412-118E8	38.93	11.40	11.01
Endothelial Cells - Artery, donor1	11264-116G4	20.94	7.56	6.11
Endothelial Cells - Artery, donor2	11341-117F9	23.29	16.94	6.35
Endothelial Cells - Artery, donor3	11413-118E9	37.52	19.11	7.01
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.04	25.05	11.08
Endothelial Cells - Lymphatic, donor2	11317-117D3	66.03	23.12	7.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	57.23	16.07	8.18
Endothelial Cells - Microvascular, donor1	11265-116G5	71.91	14.56	7.43
Endothelial Cells - Microvascular, donor2	11342-117G1	58.31	18.22	8.33
Endothelial Cells - Microvascular, donor3	11414-118F1	28.92	7.94	5.25
Endothelial Cells - Thoracic, donor1	11266-116G6	89.63	30.81	15.60
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	5.77	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	112.57	53.80	13.79
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.28	15.64	12.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	43.11	19.91	15.63
Endothelial Cells - Vein, donor1	11267-116G7	12.51	9.10	4.55
Endothelial Cells - Vein, donor2	11344-117G3	30.04	8.38	6.99
Endothelial Cells - Vein, donor3	11416-118F3	32.50	15.39	10.36
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	7.13	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	31.27	5.62	7.09
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.91	11.49	8.21
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.31	6.57	4.71
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	34.67	14.84	6.50
Fibroblast - Aortic Adventitial, donor1	11245-116E3	60.88	32.26	9.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	62.23	19.52	7.51
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.01	10.97	5.59
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.46	11.07	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	41.86	19.60	6.31
Fibroblast - Cardiac, donor1	11268-116G8	23.59	11.79	9.07
Fibroblast - Cardiac, donor2	11345-117G4	13.64	13.64	3.79
Fibroblast - Cardiac, donor3	11417-118F4	15.46	8.20	4.10
Fibroblast - Cardiac, donor4	11452-119A3	54.26	19.10	6.97
Fibroblast - Cardiac, donor5	11456-119A7	47.08	18.91	11.42
Fibroblast - Cardiac, donor6	11460-119B2	39.57	18.65	8.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	54.40	9.78	4.42
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.89	7.77	7.33
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	16.11	16.11
Fibroblast - Conjunctival, donor1	11531-120A1	22.14	5.30	13.61
Fibroblast - Conjunctival, donor3	11692-122I9	166.72	28.66	14.42
Fibroblast - Dermal, donor1	11269-116G9	57.76	20.66	8.45
Fibroblast - Dermal, donor2	11346-117G5	49.05	17.45	13.21
Fibroblast - Dermal, donor3	11418-118F5	62.86	22.85	9.67
Fibroblast - Dermal, donor4	11450-119A1	61.38	22.27	16.28
Fibroblast - Dermal, donor5	11454-119A5	62.11	23.20	16.92
Fibroblast - Dermal, donor6	11458-119A9	60.10	28.42	19.17
Fibroblast - Gingival, donor1	11237-116D4	104.74	33.52	8.95
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	35.11	17.55	8.12
Fibroblast - Gingival, donor2	11318-117D4	63.92	32.55	14.23
Fibroblast - Gingival, donor3	11394-118C8	73.87	22.24	7.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	38.44	19.74	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.96	7.93	5.46
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	35.70	19.33	6.55
Fibroblast - Gingival, donor6 (control)	11922-125H5	44.22	24.48	5.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.12	3.88	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.15	18.13	7.31
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	48.13	20.32	7.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.54	19.74	8.67
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.55	11.59	4.70
Fibroblast - Lung, donor1	11270-116H1	19.03	1.36	5.44
Fibroblast - Lung, donor2	11347-117G6	38.80	26.86	5.97
Fibroblast - Lung, donor3	11419-118F6	28.91	17.09	7.81
Fibroblast - Lymphatic, donor1	11506-119G3	46.65	10.83	5.83
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	49.93	14.21	6.50
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	65.52	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	88.84	40.35	15.71
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.31	27.00	22.45
Fibroblast - Periodontal Ligament, donor3	11395-118C9	86.59	35.19	14.69
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.70	14.88	6.87
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	37.53	12.96	6.75
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.98	10.67	6.38
Fibroblast - Pulmonary Artery, donor1	11250-116E8	60.02	33.16	10.94
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.68	8.33	7.11
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.04	2.67	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.44	14.63	9.88
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	48.62	17.26	4.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.10	13.50	6.22
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.61	18.33	7.29
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	38.51	17.75	5.72
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	77.08	28.39	7.02
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	45.81	16.70	7.59
Fibroblast - skin normal, donor1	11553-120C5	47.58	15.26	4.27
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	56.74	26.27	5.21
Fibroblast - skin normal, donor2	11561-120D4	59.88	19.79	5.93
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	58.33	16.62	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	62.22	18.72	7.37
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	110.78	19.49	9.23
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	11.82	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	67.43	26.74	6.39
Fibroblast - skin walker warburg, donor1	11554-120C6	47.57	19.74	8.43
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.30	23.37	5.18
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	819.91	465.36	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	43.58	6.10	9.59
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	60.50	22.02	9.36
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	72.61	32.53	15.35
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	62.86	21.97	11.75
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	16.84	30.62
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.08	23.61	35.09
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	52.49	24.25	51.06
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	80.52	27.58	34.47
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.67	12.56	27.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	45.57	20.21	42.80
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	73.75	27.49	31.72
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	46.64	18.92	27.72
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	60.58	25.21	55.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	51.16	18.23	33.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	43.72	15.52	36.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.11	22.03	28.21
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.92	12.51	38.53
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.93	14.95	42.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.25	15.65	25.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.67	15.97	21.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.88	14.95	27.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.54	14.86	21.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	29.84	23.93	24.52
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.03	14.15	30.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	31.95	12.96	16.09
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.96	18.15	18.55
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	48.86	21.71	35.96
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	80.78	30.77	27.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	91.57	30.70	22.48
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.58	31.25	16.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.28	16.60	23.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	81.95	34.19	27.70
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	62.89	27.77	27.16
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	39.61	18.77	15.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.89	13.03	25.94
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.52	20.51	13.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.93	16.75	13.89
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	34.31	16.60	24.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.26	19.13	18.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.66	12.19	16.68
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.98	10.90	18.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.11	14.39	15.50
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	25.54	13.68	16.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.94	12.65	17.98
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.84	13.17	14.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.26	10.10	13.47
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	24.44	11.39	11.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	15.24	13.90
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.53	15.30	12.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.26	12.31	14.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	10.57	11.39
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.47	13.27	8.30
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.12	13.38	8.99
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	31.74	5.95	13.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.77	15.96	8.05
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.48	15.54	6.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	57.69	16.52	13.22
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	114.86	43.20	56.73
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.15	14.79	34.51
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	56.87	19.03	67.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	49.76	29.73	37.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.55	28.26	45.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.50	14.76	40.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	54.45	22.27	29.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	66.14	27.46	39.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	9.63	27.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	22.60	22.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	50.77	23.76	41.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	56.42	21.41	40.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	10.00	26.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	56.21	20.13	38.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.75	17.98	27.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	43.62	15.94	20.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	62.02	18.77	34.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.63	22.76	26.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	33.41	29.23	33.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	73.88	25.20	49.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.37	14.80	20.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	13.55	18.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	51.78	28.58	30.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	52.24	30.61	30.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	36.88	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	50.36	16.91	33.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	45.31	16.95	27.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	34.11	18.06	31.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	70.89	21.96	30.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	51.35	14.38	25.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	7.45	32.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.54	17.46	31.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	60.35	16.90	37.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	30.01	15.77	31.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	61.82	22.33	33.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	40.95	11.35	24.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	8.26	25.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	44.93	13.42	25.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	41.25	15.80	30.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	40.69	11.02	19.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	35.22	17.91	20.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	42.70	17.47	32.03
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.88	8.32	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	10.12	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	51.70	13.00	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	52.22	9.19	5.85
Hep-2 cells mock treated, biol_rep1	11898-125E8	64.40	30.87	21.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	53.51	26.67	22.62
Hep-2 cells mock treated, biol_rep3	11900-125F1	54.15	25.03	21.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	54.76	24.70	22.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	52.87	23.00	19.99
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.79	24.54	20.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.41	25.28	19.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	55.75	26.08	20.93
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	47.42	17.62	19.54
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.27	6.16	6.72
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	0.87	7.79
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	2.64	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.99	4.59	4.94
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.73	5.09
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	31.12	14.69	9.79
Hepatocyte, donor1	11523-119I2	15.74	6.05	9.68
Hepatocyte, donor2	11603-120I1	21.55	11.85	28.01
Hepatocyte, donor3	11684-122I1	26.38	6.14	11.66
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	63.31	39.16	15.66
Intestinal epithelial cells (polarized), donor1	11246-116E4	85.64	36.88	26.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	66.82	25.79	14.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	9.55	22.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	26.70
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	9.69	11.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	7.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	7.69	23.07
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	18.28
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	1.62	19.49
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	18.34	15.01
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	43.67	13.23	19.85
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	9.98	13.30
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	15.71	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	42.83	16.38	27.71
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	13.92	27.84
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	37.47	10.98	25.20
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	11.27	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.11	8.96	27.71
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	34.00	13.85	9.24
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	43.12
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	38.58	7.23	28.93
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	25.85	20.31	23.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	42.01	20.77	34.93
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.02	9.07	19.05
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	11.84	27.98
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	5.08	19.06
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	34.43	8.93	32.52
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	5.47	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	5.71	27.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	6.64	29.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	41.70
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.93	13.89	28.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	5.27	22.83
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	6.29	25.15
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.21	8.34	25.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	6.64	22.13
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	19.45
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	6.10	31.39
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	4.50	18.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	20.91
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	6.40	34.14
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	6.93	19.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	0.00	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	1.84	23.93
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	9.08	15.13
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	25.38	5.29	23.26
Keratinocyte - epidermal, donor1	11272-116H3	66.58	24.23	10.36
Keratinocyte - epidermal, donor2	11349-117G8	46.85	9.96	9.96
Keratinocyte - epidermal, donor3	11421-118F8	65.60	27.26	22.34
Keratinocyte - oral, donor1	11251-116E9	227.94	51.76	29.74
Keratocytes, donor1	11527-119I6	25.79	7.22	14.10
Keratocytes, donor2	11607-120I5	16.41	3.52	8.20
Keratocytes, donor3	11688-122I5	19.56	8.30	9.29
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	4.40	15.39
Lens Epithelial Cells, donor1	11529-119I8	38.83	14.02	11.87
Lens Epithelial Cells, donor2	11609-120I7	115.68	29.29	22.14
Lens Epithelial Cells, donor3	11690-122I7	58.93	20.28	8.27
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	49.21	17.79	6.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.05	10.88	5.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	51.47	19.68	5.35
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.42	10.75	5.38
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.06	9.14	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.17	7.76	4.31
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.24	13.13	5.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.44	4.80	3.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	32.23	8.59	5.35
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	11.07	5.54
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	44.40	13.38	6.20
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.44	4.63	3.52
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	38.68	10.10	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	42.46	10.50	5.49
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.82	6.87	3.57
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.95	15.09	4.93
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	25.56	5.30	3.12
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.12	8.60	3.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.16	14.15	6.25
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.94	3.51	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.92	3.49	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	48.98	11.64	6.79
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	30.43	11.31	6.19
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.91	10.60	6.81
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.18	9.33	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.04	15.91	7.54
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.77	9.77	3.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	6.19	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	35.56	12.04	5.46
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.33	5.30	5.41
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.04	8.24	6.30
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	25.47	7.61	3.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.53	6.69	2.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.43	11.48	5.55
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.12	9.88	5.93
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.71	7.56	2.34
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	39.56	12.22	6.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.69	9.43	7.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	43.25	16.24	5.04
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.11	11.73	4.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.30	3.88	4.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.27	5.14	2.49
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.29	11.46	4.30
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	20.58	6.86	4.90
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.48	4.71	2.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	41.33	15.96	6.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.93	5.38	3.07
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.01	11.04	5.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	49.85	9.06	9.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	44.49	9.97	5.37
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	10.39	8.16
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.93	10.16	11.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.06	5.63	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	11.21	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	37.61	8.24	11.34
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	3.57	8.33
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	56.32	12.21	13.57
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.80	10.47	9.31
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.27	18.46	9.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	67.61	13.96	10.84
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	37.49	6.68	12.84
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.46	11.29	9.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	32.65	14.66	5.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	43.30	5.60	15.28
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.29	12.54	15.74
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	47.61	7.94	14.55
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	59.52	4.91	11.66
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.11	11.42	12.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.77	13.54	13.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	61.10	12.61	12.89
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	35.03	7.21	12.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.58	8.71	15.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	49.62	9.86	16.14
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	43.71	12.17	11.62
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	47.37	6.36	12.73
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	59.37	11.06	13.28
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	34.54	5.76	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.21	10.75	11.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.25	11.89	10.76
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.05	13.95	10.67
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	41.57	10.85	7.68
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	70.38	6.46	10.77
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	9.71	16.43
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	45.71	8.92	13.38
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	62.46	11.63	12.92
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	5.99	17.13
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.65	6.33	11.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	49.47	11.46	11.46
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.99	9.95	7.82
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	35.75	9.97	12.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	46.16	10.73	9.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.69	7.41	8.08
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	51.86	12.22	10.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	8.14	10.47
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	13.75	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	41.22	8.80	11.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	45.79	4.36	9.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	36.03	12.26	7.67
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.85	9.37	12.33
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	6.59	8.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	40.73	9.55	14.08
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.92	6.76	14.42
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	68.84	3.44	12.05
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	39.64	11.13	10.69
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	41.06	8.21	10.95
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	58.72	9.90	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	43.07	9.86	16.09
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.32	10.06	14.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	63.74	13.42	10.62
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.54	8.39	14.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.91	6.56	11.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	72.92	8.61	10.63
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.58	10.57	12.02
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	55.66	7.55	13.52
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	72.91	15.19	12.76
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	50.49	13.83	9.68
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	46.74	13.30	12.16
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.27	7.75	15.49
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	56.23	9.67	13.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	59.89	10.46	13.31
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	57.57	7.46	11.19
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	50.57	3.45	9.19
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	42.68	4.11	8.23
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	52.34	9.90	15.56
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	48.24	13.05	9.65
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.84	13.31	9.98
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	71.26	10.18	17.23
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	62.21	9.19	8.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	50.18	8.83	10.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.83	10.70	6.02
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	59.88	12.83	14.97
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	46.47	12.93	11.72
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.96	11.01	13.77
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	62.24	4.45	13.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	9.12	15.96
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	44.48	9.97	13.80
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	45.96	14.23	13.68
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	9.35	13.81
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	54.07	17.94	14.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.74	15.25	14.59
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	12.47
Macrophage - monocyte derived, donor1	11232-116C8	36.01	14.36	3.65
Macrophage - monocyte derived, donor2	11313-117C8	37.44	16.88	3.85
Macrophage - monocyte derived, donor3	11389-118C3	25.43	12.45	4.98
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	67.97	22.83	9.03
Mallassez-derived cells, donor2	11929-125I3	49.60	29.63	12.36
Mallassez-derived cells, donor3	11930-125I4	77.28	30.99	21.68
Mammary Epithelial Cell, donor1	11273-116H4	123.86	43.25	22.92
Mammary Epithelial Cell, donor2	11350-117G9	106.84	38.80	26.64
Mammary Epithelial Cell, donor3	11422-118F9	34.42	12.97	6.73
Mast cell - stimulated, donor1	11487-119E2	75.93	40.68	24.41
Mast cell, donor1	11563-120D6	49.42	14.49	6.92
Mast cell, donor2	11565-120D8	40.71	11.29	4.75
Mast cell, donor3	11566-120D9	38.72	11.48	3.38
Mast cell, donor4	11567-120E1	37.76	10.46	3.01
Mast cell, expanded and stimulated, donor5	11940-126A5	48.68	23.51	3.88
Mast cell, expanded and stimulated, donor8	11942-126A7	75.30	26.85	7.59
Mast cell, expanded, donor5	11939-126A4	49.79	18.24	4.93
Mast cell, expanded, donor8	11941-126A6	60.59	16.40	4.02
Melanocyte - dark, donor1	11502-119F8	79.90	37.71	9.55
Melanocyte - dark, donor2	11582-120F7	40.15	18.34	4.15
Melanocyte - dark, donor3	11663-122F7	54.11	30.06	9.42
Melanocyte - light, donor1	11274-116H5	15.51	2.82	1.41
Melanocyte - light, donor2	11351-117H1	12.28	4.78	2.05
Melanocyte - light, donor3	11423-118G1	10.41	2.60	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	24.68	13.85	10.62
Melanocyte, donor2 (MC+2)	12739-135I3	31.74	12.91	5.65
Melanocyte, donor3 (MC+3)	12837-137B2	19.82	4.82	2.95
Meningeal Cells, donor1	11493-119E8	67.12	19.48	14.39
Meningeal Cells, donor2	11573-120E7	43.57	13.20	7.48
Meningeal Cells, donor3	11654-122E7	103.18	47.03	15.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	108.93	39.64	15.11
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	59.37	19.52	9.46
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	19.71	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	17.94	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.14	14.61	7.41
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	34.68	9.05	6.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.47	7.91	6.81
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	7.31	8.04
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.82	3.68	6.34
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	126.87	24.10	7.34
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.27	2.60	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	75.00	24.60	8.95
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.74	5.34	3.56
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	6.40	5.76
Mesenchymal stem cells - adipose, donor0	11217-116B2	85.78	35.44	17.37
Mesenchymal stem cells - hepatic, donor0	11218-116B3	68.49	25.64	8.44
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	22.50	16.69
Mesothelial Cells, donor1	11247-116E5	40.57	13.79	9.28
Mesothelial Cells, donor2	12156-128G5	28.53	10.51	3.50
Mesothelial Cells, donor3	11402-118D7	23.99	10.19	9.54
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.19	9.36	3.69
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.09	6.77	3.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	6.82	4.03
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.89	9.13	4.56
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.77	8.01	2.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.95	7.91	3.26
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.92	6.71	2.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	5.94	2.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	10.62	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.02	9.88	4.56
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.04	9.97	3.18
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	4.60	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	6.86	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.32	9.03	2.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.11	6.42	3.09
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	1.66	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.82	9.90	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.82	9.04	4.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	8.97	3.87
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.38	9.44	2.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.12	5.56	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.76	5.69	4.38
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	2.53	5.07
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	5.71	3.26
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.29	5.59	3.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	1.09	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.90	6.25	3.36
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.21	5.60	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.01	6.01	5.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	6.57	7.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	3.31	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	3.20	4.48
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.13	8.68	5.45
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	2.78	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	9.57	3.76
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	1.31	3.94
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	2.13	3.20
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.71	10.10	5.89
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	2.49	4.99
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	0.58	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.65	4.52	4.22
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	6.26	4.17
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	4.62	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	3.41	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.57	2.63	4.70
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	7.52	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.15	4.72	6.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	0.64	4.45
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.60	2.67	4.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.46	5.69	4.49
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	3.39	4.66
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.65	7.01	3.50
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.37	4.86	4.86
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.31	1.14	3.03
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.35	6.53	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.21	7.87	3.69
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	1.30	5.87
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.00	2.94	4.12
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.89	8.36	3.17
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	7.83	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	3.87	2.98
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	11.30	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.19	4.60	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	9.47	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.73	8.30	3.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	9.31	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.27	6.76	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.92	7.46	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.41	12.21	3.96
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	7.37	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.53	4.03	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	6.22	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	32.60	11.76	5.88
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	8.08	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.81	5.48	5.90
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	21.79	9.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	31.15	10.17	6.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	33.20	13.77	5.67
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	16.61	12.08
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	17.13	34.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	16.31	29.36
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	28.51	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	75.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	55.58	22.84	9.91
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	48.08	14.11	11.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	6.01	9.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	5.01	10.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	24.72	13.31	7.61
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	9.58	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	3.40	8.16
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	86.37	60.64	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	9.21	8.37
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	24.87	9.07	10.69
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	2.70	6.22
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.27	5.89	4.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	423.12	267.23	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	29.29	10.92	4.96
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	27.88	4.87	5.41
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.21	6.12	7.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.08	2.78	11.59
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.97	9.48	4.74
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.87	6.37	9.55
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	3.00	7.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	36.76	8.86	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.59	3.58	7.64
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.28	8.64	5.82
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	3.52	8.44
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	3.68	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	5.78	7.71
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.76	10.69	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	48.04	42.98	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.26	6.02	6.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	4.23	8.04
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.72	4.27	6.41
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	4.29	11.16
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	397.22	126.39	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.66	2.00	8.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	1.80	5.86
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.25	4.76	11.11
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	7.43	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	11.73	6.81	6.05
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.64	4.24	11.08
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.49	0.00	7.84
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	7.69	13.57
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	2.65	10.58
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	2.66	12.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	4.46	10.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.57	2.30	10.72
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	2.12	4.84
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.08	8.40	6.41
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	2.71	16.94
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	56.20	25.55
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	2.44	8.54
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.50	3.78	6.29
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	0.30	8.47
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	21.36	6.33	7.12
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	11.34	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	50.58	15.17
Myoblast, donor1	11241-116D8	54.78	21.24	10.31
Myoblast, donor2	11322-117D8	48.91	13.81	7.10
Myoblast, donor3	11398-118D3	56.50	23.88	9.75
NK T cell leukemia cell line:KHYG-1	10777-110G3	64.21	25.98	15.61
Natural Killer Cells, donor1	11230-116C6	62.73	18.76	5.54
Natural Killer Cells, donor2	11311-117C6	35.89	8.75	4.82
Natural Killer Cells, donor3	11387-118C1	42.88	11.23	9.20
Neural stem cells, donor1	11275-116H6	98.36	43.19	15.24
Neural stem cells, donor2	11352-117H2	77.03	32.74	48.14
Neurons, donor1	11494-119E9	48.93	17.07	40.96
Neurons, donor2	11574-120E8	77.50	32.80	37.65
Neurons, donor3	11655-122E8	22.20	22.20	45.22
Neutrophils, donor1	11233-116C9	4.64	0.93	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	7.33	3.05	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	128.83	28.38	11.75
Nucleus Pulposus Cell, donor2	11409-118E5	71.63	7.49	5.54
Nucleus Pulposus Cell, donor3	11462-119B4	52.34	12.23	10.43
Olfactory epithelial cells, donor1	11933-125I7	27.67	12.66	7.43
Olfactory epithelial cells, donor2	11934-125I8	37.78	19.69	6.80
Olfactory epithelial cells, donor3	11935-125I9	38.71	15.89	5.11
Olfactory epithelial cells, donor4	11936-126A1	35.26	13.05	8.86
Oligodendrocyte - precursors, donor1	11496-119F2	55.37	25.28	22.27
Osteoblast - differentiated, donor1	11276-116H7	46.15	7.02	5.32
Osteoblast - differentiated, donor2	11353-117H3	18.29	2.29	3.43
Osteoblast - differentiated, donor3	11425-118G3	19.86	5.59	2.48
Osteoblast, donor1	11277-116H8	39.09	14.27	8.40
Osteoblast, donor2	11354-117H4	50.57	25.99	7.73
Osteoblast, donor3	11426-118G4	31.28	11.37	8.35
Pancreatic stromal cells, donor1	11249-116E7	86.85	31.34	7.16
Pericytes, donor1	11491-119E6	21.70	3.67	2.45
Pericytes, donor2	11571-120E5	12.22	2.04	3.85
Pericytes, donor3	11652-122E5	18.92	5.29	6.31
Perineurial Cells, donor1	11499-119F5	70.98	30.29	14.47
Perineurial Cells, donor2	11579-120F4	78.95	33.68	10.21
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	78.09	13.07	8.29
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.81	9.79	3.43
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	34.68	9.58	4.66
Placental Epithelial Cells, donor1	11278-116H9	12.91	6.46	8.13
Placental Epithelial Cells, donor2	11355-117H5	23.29	3.33	1.11
Placental Epithelial Cells, donor3	11427-118G5	19.24	7.26	5.30
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	7.59	1.58
Preadipocyte - breast, donor1	11467-119B9	35.83	11.82	5.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.07	15.27	2.09
Preadipocyte - breast, donor2	11328-117E5	22.06	7.66	3.15
Preadipocyte - omental, donor1	11468-119C1	32.18	12.15	5.54
Preadipocyte - omental, donor2	11329-117E6	26.19	9.60	3.93
Preadipocyte - omental, donor3	11403-118D8	22.78	12.89	6.45
Preadipocyte - perirenal, donor1	11469-119C2	13.78	3.94	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	26.10	14.74	4.61
Preadipocyte - subcutaneous, donor2	11356-117H6	52.24	36.30	6.02
Preadipocyte - subcutaneous, donor3	11428-118G6	45.13	21.80	6.47
Preadipocyte - visceral, donor1	11280-116I2	85.04	35.40	9.13
Preadipocyte - visceral, donor2	11357-117H7	50.62	15.65	5.06
Preadipocyte - visceral, donor3	11429-118G7	37.83	22.67	5.54
Prostate Epithelial Cells (polarized), donor1	11253-116F2	75.43	36.51	35.30
Prostate Epithelial Cells, donor2	11331-117E8	35.61	11.51	9.75
Prostate Epithelial Cells, donor3	11404-118D9	50.40	14.39	24.37
Prostate Stromal Cells, donor1	11254-116F3	66.29	30.07	13.78
Prostate Stromal Cells, donor2	11332-117E9	51.82	23.13	12.19
Prostate Stromal Cells, donor3	11405-118E1	34.20	13.56	5.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.74	5.11	9.12
Renal Cortical Epithelial Cells, donor2	11596-120H3	97.66	27.72	24.19
Renal Epithelial Cells, donor1	11517-119H5	11.16	2.03	7.61
Renal Epithelial Cells, donor2	11597-120H4	16.36	3.56	10.67
Renal Epithelial Cells, donor3	11678-122H4	141.44	37.90	25.09
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	2.04	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	22.37	8.09	7.41
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.30	12.43	10.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	1.33	2.66
Renal Mesangial Cells, donor1	11518-119H6	23.33	6.60	6.82
Renal Mesangial Cells, donor2	11598-120H5	17.56	6.27	10.66
Renal Mesangial Cells, donor3	11679-122H5	10.82	1.94	4.16
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	57.17	11.81	26.31
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.30	2.95	12.23
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.23	5.98	9.64
Retinal Pigment Epithelial Cells, donor0	11215-116A9	83.23	26.45	20.48
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.77	9.10	9.95
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	5.15	7.20
Retinal Pigment Epithelial Cells, donor3	11689-122I6	108.39	17.56	30.61
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	41.69	16.04	4.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	59.86	18.76	19.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	152.45	60.54	15.96
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	66.13	25.52	20.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	86.86	31.73	19.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.92	23.63	22.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	118.90	43.95	30.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	115.48	46.27	33.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	63.98	26.81	21.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	64.25	35.59	29.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	48.33	18.76	18.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.10	25.87	17.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	79.56	32.97	22.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	62.69	22.09	16.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	55.70	27.58	21.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.41	25.89	18.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.06	19.12	17.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	54.31	24.41	22.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	133.41	43.78	26.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	54.81	15.26	18.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.10	27.35	19.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	75.05	33.42	21.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	58.20	19.33	19.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.01	24.67	15.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	56.91	28.20	23.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	47.59	18.23	17.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.51	26.86	20.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	74.14	33.71	29.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	66.04	25.95	20.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	56.75	20.44	22.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	45.83	28.06	23.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	55.57	24.05	22.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.43	28.76	19.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.53	29.45	20.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	61.91	22.74	19.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.77	15.33	20.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	55.72	24.87	21.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	62.76	24.59	15.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.08	16.32	19.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	74.37	31.03	20.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	50.45	15.85	13.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	69.98	36.10	22.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	47.71	26.66	20.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	77.98	15.21	19.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	70.24	28.57	23.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	68.12	30.84	21.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	80.71	27.69	16.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.02	38.78	29.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	52.59	20.85	14.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.43	28.27	15.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	147.88	52.54	34.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.67	29.81	16.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	56.36	25.92	14.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	76.90	21.71	24.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	74.59	26.06	23.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	108.51	30.94	17.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	68.52	23.27	18.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	61.90	16.23	23.44
Schwann Cells, donor1	11498-119F4	18.62	3.95	5.08
Schwann Cells, donor2	11578-120F3	40.83	13.61	13.61
Schwann Cells, donor3	11659-122F3	36.15	12.71	8.33
Sebocyte, donor1	11220-116B5	66.83	26.29	14.79
Sebocyte, donor2	11301-117B5	39.52	9.65	11.49
Sebocyte, donor3	11378-118B1	32.57	9.89	4.95
Sertoli Cells, donor1	11255-116F4	71.23	23.19	14.91
Sertoli Cells, donor2	11333-117F1	76.26	2.82	11.30
Skeletal Muscle Cells, donor1	11281-116I3	77.24	18.92	16.01
Skeletal Muscle Cells, donor2	11358-117H8	14.46	2.17	4.34
Skeletal Muscle Cells, donor3	11430-118G8	25.92	9.20	6.69
Skeletal Muscle Cells, donor4	11451-119A2	57.18	19.48	17.75
Skeletal Muscle Cells, donor5	11455-119A6	56.19	19.62	15.76
Skeletal Muscle Cells, donor6	11459-119B1	52.63	29.24	19.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	150.33	40.07	11.34
Skeletal Muscle Satellite Cells, donor2	11321-117D7	71.92	17.12	9.70
Skeletal Muscle Satellite Cells, donor3	11397-118D2	55.36	25.40	18.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	78.86	26.37	13.23
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	5.79	10.13
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.54	6.33	4.40
Skin - palm, donor1	10286-104F7	10.74	5.37	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.86	11.53	10.81
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	48.26	17.99	15.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	33.88	12.72	10.00
Small Airway Epithelial Cells, donor1	11256-116F5	108.01	32.81	23.35
Small Airway Epithelial Cells, donor2	11334-117F2	38.26	12.52	14.21
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	83.10	36.16	17.97
Small Airway Epithelial Cells, donor3	11406-118E2	37.48	11.62	15.74
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	46.29	18.21	8.33
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	33.79	8.45	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.92	15.28	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	29.83	9.72	5.08
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.69	6.69	5.51
Smooth Muscle Cells - Aortic, donor3	11432-118H1	41.72	14.68	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	40.03	13.01	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	39.52	14.37	5.19
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	50.98	19.06	8.87
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	50.57	13.57	14.34
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	65.44	21.16	8.47
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.33	22.74	10.04
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.22	10.53	5.27
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.15	3.25	4.07
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.75	6.09	10.35
Smooth Muscle Cells - Carotid, donor1	11285-116I7	52.79	15.91	3.79
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	4.77	8.58
Smooth Muscle Cells - Colonic, donor1	11239-116D6	39.97	18.29	5.90
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.70	12.91	7.32
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.65	15.74	10.29
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	28.31	7.89	4.02
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	5.39	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.40	10.16	8.67
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.92	4.10	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	133.66	29.92	13.27
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	76.89	22.34	10.67
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.31	16.84	10.47
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.78	8.45	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.50	41.59	30.47
Smooth Muscle Cells - Prostate, donor1	11257-116F6	79.50	26.23	11.19
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.94	16.53	7.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	48.96	15.47	8.12
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	57.60	20.20	8.29
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	3.00	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	7.75	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.09	13.02	7.91
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.74	10.10	5.05
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	27.58	7.83	7.21
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.60	2.95	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.40	34.07	12.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.91	8.88	5.61
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.93	10.22	9.35
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	33.91	14.28	9.18
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.90	9.03	6.21
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	87.34	31.72	13.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	77.25	26.90	11.14
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	0.95	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	32.05	10.77	9.05
Smooth Muscle Cells - Uterine, donor1	11258-116F7	54.13	17.23	7.51
Smooth Muscle Cells - Uterine, donor3	11466-119B8	54.71	23.11	9.95
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.02	3.50	3.30
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.93	8.20	4.23
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	37.94	17.48	5.58
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.26	7.55	6.47
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.14	5.96	9.08
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.12	20.48	9.85
Smooth muscle cells - airway, control, donor1	11966-126D4	24.89	7.36	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	22.76	5.59	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	5.43	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	27.50	5.50	2.75
Synoviocyte, donor1	11291-117A4	51.17	23.40	8.25
Synoviocyte, donor2	11368-117I9	41.57	11.06	5.53
Synoviocyte, donor3	11440-118H9	42.89	13.63	4.24
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	6.43	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	3.70	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	73.69	19.35	17.06
Tracheal Epithelial Cells, donor2	11369-118A1	37.88	11.21	11.21
Tracheal Epithelial Cells, donor3	11441-118I1	38.37	9.74	12.60
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	45.27	12.43	5.54
Urethra, donor2	10319-105A4	19.78	3.60	10.79
Urothelial Cells, donor1	11520-119H8	24.18	3.98	6.64
Urothelial Cells, donor2	11600-120H7	16.02	5.21	5.21
Urothelial Cells, donor3	11681-122H7	15.36	2.75	3.44
Urothelial cells, donor0	11216-116B1	84.03	23.40	16.72
Whole blood (ribopure), donor090309, donation1	12179-129A1	47.16	13.35	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	41.46	7.15	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	3.42	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.78	12.74	4.48
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	11.62	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	36.44	7.29	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	11.01	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	57.86	24.43	17.64
Wilms' tumor cell line:HFWT	10597-108E3	33.44	7.92	34.32
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	51.95	16.48	18.43
achilles tendon, donor2	10292-104G4	18.60	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	93.82	49.46	22.95
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	70.12	46.67	10.68
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	100.19	51.40	20.06
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	89.53	45.72	13.61
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	90.23	41.32	28.95
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	69.37	36.80	9.94
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	111.61	34.03	17.69
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	266.59	92.53	37.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	52.68	26.95	11.84
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	70.67	46.98	20.19
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	107.09	38.64	25.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	117.02	58.51	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	89.00	45.55	11.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	135.92	54.37	27.18
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	103.16	42.08	17.83
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	36.25	20.91	12.55
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	51.00	18.10	15.63
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.27	10.44	60.16
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	132.71	67.85	28.59
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	157.71	69.76	30.63
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	185.82	67.16	32.25
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	94.44	41.87	30.52
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	59.37	18.35	26.02
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	16.72	48.31
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	112.62	48.21	41.43
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	93.33	33.15	29.22
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	15.00	24.37
adenocarcinoma cell line:IM95m	10796-110I4	51.34	24.96	9.18
adipose tissue, adult, pool1	10010-101C1	48.09	15.98	8.53
adipose, donor1	10184-103D4	113.76	53.36	23.46
adipose, donor2	10185-103D5	39.74	14.19	27.17
adipose, donor3	10186-103D6	46.56	20.69	19.60
adipose, donor4	10187-103D7	37.27	18.20	25.14
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	54.92	11.05	22.73
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	25.46
adult T-cell leukemia cell line:ATN-1	10421-106C7	97.39	33.62	12.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	88.61	42.52	21.80
amniotic membrane cells, donor1	12235-129G3	51.93	21.79	9.27
amniotic membrane cells, donor2	12236-129G4	37.53	16.91	9.80
amniotic membrane cells, donor3	12237-129G5	65.11	11.19	9.13
amygdala - adult, donor10196	10167-103B5	54.55	20.16	30.83
amygdala, adult, donor10252	10151-102I7	55.56	12.37	16.63
amygdala, newborn, donor10223	10360-105E9	40.35	10.65	17.43
anaplastic carcinoma cell line:8305C	10428-106D5	203.47	31.20	29.29
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	78.54	49.42	34.20
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.74	18.71	30.40
aorta, adult, pool1	10052-101G7	18.63	5.69	7.65
appendix, adult	10189-103D9	25.62	6.99	9.70
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	135.17	35.08	18.57
artery, adult	10190-103E1	40.76	9.51	12.23
astrocytoma cell line:TM-31	10425-106D2	82.57	26.80	37.52
b cell line:RPMI1788	10427-106D4	96.95	30.04	17.10
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.06	19.70	8.88
bile duct carcinoma cell line:HuCCT1	10432-106D9	128.31	36.32	32.65
bile duct carcinoma cell line:TFK-1	10496-107C1	28.12	5.36	9.88
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	124.15	26.28	25.72
bladder, adult, pool1	10011-101C2	33.24	9.99	8.15
blood, adult, pool1	10053-101G8	22.15	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	11.13	0.00
bone marrow, adult	10192-103E3	40.49	18.22	11.47
brain, adult, donor1	10084-102B3	29.73	6.15	18.45
brain, adult, pool1	10012-101C3	69.49	25.84	14.37
brain, fetal, pool1	10085-102B4	37.40	0.00	26.71
breast carcinoma cell line:MCF7	10482-107A5	79.62	20.15	21.47
breast carcinoma cell line:MDA-MB-453	10419-106C5	118.46	42.07	10.36
breast, adult, donor1	10080-102A8	15.15	3.79	6.94
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.37	25.41	19.18
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.40	23.50	30.30
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	138.59	63.31	19.57
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	62.46	19.61	18.88
carcinoid cell line:NCI-H1770	10703-109H1	96.38	28.21	118.01
carcinoid cell line:NCI-H727	10735-110B6	84.99	36.86	42.00
carcinoid cell line:SK-PN-DW	10719-109I8	110.28	29.15	25.03
carcinosarcoma cell line:JHUCS-1	10642-109A3	93.69	33.80	46.05
caudate nucleus - adult, donor10196	10177-103C6	39.14	23.03	19.57
caudate nucleus, adult, donor10252	10164-103B2	56.72	20.75	8.70
caudate nucleus, adult, donor10258	10379-105H1	79.47	19.87	6.88
caudate nucleus, newborn, donor10223	10354-105E3	50.91	19.78	11.72
cerebellum - adult, donor10196	10173-103C2	58.27	29.13	32.05
cerebellum, adult, donor10252	10166-103B4	82.84	20.50	24.98
cerebellum, adult, pool1	10083-102B2	49.67	10.69	18.63
cerebellum, newborn, donor10223	10357-105E6	70.57	11.62	11.62
cerebral meninges, adult	10188-103D8	58.24	12.35	20.42
cerebrospinal fluid, donor2	10294-104G6	27.04	2.92	16.08
cervical cancer cell line:D98-AH2	10552-107I3	79.80	17.25	14.23
cervical cancer cell line:ME-180	10553-107I4	87.17	28.34	17.73
cervix, adult, pool1	10013-101C4	38.22	10.50	6.93
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	78.73	25.50	20.20
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	1.31	10.45
choriocarcinoma cell line:BeWo	10423-106C9	211.77	57.79	54.43
choriocarcinoma cell line:SCH	10785-110H2	41.03	15.16	18.97
choriocarcinoma cell line:T3M-3	10618-108G6	46.96	11.62	24.67
chorionic membrane cells, donor1	12238-129G6	29.35	10.54	7.12
chorionic membrane cells, donor2	12239-129G7	31.82	19.19	7.16
chorionic membrane cells, donor3	12240-129G8	30.22	9.34	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	78.76	44.43	10.10
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	75.69	39.76	15.37
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	65.05	24.29	17.74
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	85.77	34.15	53.67
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	94.09	37.25	46.44
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	90.81	38.89	48.87
chronic myelogenous leukemia cell line:K562	10454-106G4	157.83	63.31	55.95
chronic myelogenous leukemia cell line:KU812	10409-106B4	161.33	49.00	38.31
clear cell carcinoma cell line:JHOC-5	10638-108I8	50.75	21.72	15.77
clear cell carcinoma cell line:TEN	10636-108I6	84.32	31.40	11.97
colon carcinoma cell line:CACO-2	10513-107D9	99.39	51.98	34.59
colon carcinoma cell line:COLO-320	10420-106C6	192.70	51.31	33.07
colon, adult, donor1	10082-102B1	23.80	7.14	8.33
colon, adult, pool1	10014-101C5	40.42	11.40	4.94
colon, fetal, donor1	10070-101I7	25.34	6.80	4.94
common myeloid progenitor CMP, donor1	12130-128D6	41.25	9.17	22.92
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	90.09	41.22	16.57
cord blood derived cell line:COBL-a 24h infection	10453-106G3	88.14	40.75	11.17
cord blood derived cell line:COBL-a untreated	10449-106F8	95.75	56.69	12.97
corpus callosum, adult, pool1	10042-101F6	36.82	9.40	11.72
cruciate ligament, donor2	10295-104G7	16.21	3.24	11.35
diaphragm, fetal, donor1	10069-101I6	30.50	5.62	12.04
diencephalon, adult	10193-103E4	34.32	9.60	16.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	73.25	39.26	15.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	83.86	23.08	24.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	185.84	41.64	45.98
ductus deferens, adult	10196-103E7	23.42	5.98	7.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	7.20	11.52
duodenum, fetal, donor1, tech_rep2	10071-101I8	56.64	11.77	13.24
dura mater, adult, donor1	10041-101F5	59.38	19.00	9.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	87.27	14.21	107.26
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	122.80	35.82	79.53
embryonic pancreas cell line:1B2C6	10604-108F1	32.06	6.17	26.51
embryonic pancreas cell line:1C3D3	10605-108F2	60.54	15.74	13.92
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.77	9.57	26.24
embryonic pancreas cell line:2C6	10603-108E9	36.78	13.13	24.96
endometrial carcinoma cell line:OMC-2	10497-107C2	58.32	21.12	34.86
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	86.81	21.20	18.85
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	52.59	24.60	10.45
epidermoid carcinoma cell line:A431	10426-106D3	64.58	22.45	16.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	81.50	37.29	33.77
epididymis, adult	10197-103E8	29.51	5.86	5.86
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	100.59	33.71	17.56
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.14	20.45	12.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	53.47	29.88	16.25
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.28	22.64	18.60
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	52.21	26.10	16.69
esophagus, adult, pool1	10015-101C6	51.07	13.70	4.88
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	132.25	38.70	9.39
eye - muscle inferior rectus, donor1	10272-104E2	19.32	0.00	9.66
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	10.52
eye - muscle medial, donor2	10299-104H2	1.49	0.00	7.44
eye - muscle superior, donor2	10297-104G9	19.49	3.44	13.76
eye - vitreous humor, donor1	10268-104D7	26.23	5.83	5.83
eye, fetal, donor1	10054-101G9	35.08	12.20	16.53
fibrosarcoma cell line:HT-1080	10758-110E2	63.47	27.95	25.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	67.90	18.99	17.57
frontal lobe, adult, pool1	10040-101F4	124.88	35.09	23.27
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	44.44	19.52	14.71
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	57.79	24.14	7.13
gall bladder, adult	10198-103E9	37.90	9.66	8.21
gamma delta positive T cells, donor1	11937-126A2	49.39	20.94	2.68
gamma delta positive T cells, donor2	11938-126A3	44.45	14.57	5.23
gastric adenocarcinoma cell line:MKN1	10614-108G2	79.21	27.25	20.28
gastric adenocarcinoma cell line:MKN45	10612-108F9	98.84	37.33	23.79
gastric cancer cell line:AZ521	10549-107H9	134.61	57.71	34.92
gastric cancer cell line:GSS	10560-108A2	84.20	26.54	15.56
gastrointestinal carcinoma cell line:ECC12	10615-108G3	65.11	13.02	33.13
giant cell carcinoma cell line:LU65	10487-107B1	56.68	8.72	43.72
giant cell carcinoma cell line:Lu99B	10433-106E1	285.24	66.90	23.79
glassy cell carcinoma cell line:HOKUG	10688-109F4	46.64	14.47	16.46
glioblastoma cell line:A172, tech_rep1	10444-106F3	65.97	33.99	11.93
glioblastoma cell line:A172, tech_rep2	10444-106F3	56.32	32.16	12.22
glioblastoma cell line:T98G	10485-107A8	155.30	87.31	19.32
glioma cell line:GI-1	10413-106B8	58.87	28.41	15.52
globus pallidus - adult, donor10196	10175-103C4	15.31	8.02	17.49
globus pallidus, adult, donor10252	10161-103A8	36.37	15.13	14.65
globus pallidus, adult, donor10258	10367-105F7	17.80	4.11	20.54
globus pallidus, newborn, donor10223	10364-105F4	30.91	10.66	12.79
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	17.13	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	27.20	15.04	10.56
hIPS +CCl2, biol_rep1	14383-156B9	44.07	17.45	33.97
hIPS +CCl2, biol_rep2	14384-156C1	43.90	10.52	27.44
hIPS +CCl2, biol_rep3	14385-156C2	14.17	12.24	36.07
hIPS, biol_rep1	14380-156B6	18.68	14.37	35.93
hIPS, biol_rep2	14381-156B7	5.49	8.92	32.24
hIPS, biol_rep3	14382-156B8	25.38	7.72	24.28
hairy cell leukemia cell line:Mo	10712-109I1	90.51	31.61	17.82
heart - mitral valve, adult	10205-103F7	25.41	5.68	5.38
heart - pulmonic valve, adult	10206-103F8	28.24	13.86	9.94
heart - tricuspid valve, adult	10207-103F9	20.82	12.49	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	17.14	6.73	7.35
heart, adult, diseased, donor1	10051-101G6	11.92	2.98	7.24
heart, adult, pool1	10016-101C7	13.57	5.75	6.44
heart, fetal, pool1	10046-101G1	50.01	12.94	14.79
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	7.40	7.40
hepatoblastoma cell line:HuH-6	10633-108I3	55.89	16.65	34.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	99.23	69.39	48.18
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	114.94	77.80	55.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	130.36	83.77	51.64
hepatoma cell line:Li-7	10484-107A7	56.83	29.69	35.81
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	97.99	38.79	40.30
hippocampus - adult, donor10196	10169-103B7	35.96	13.25	25.55
hippocampus, adult, donor10252	10153-102I9	46.13	12.86	12.86
hippocampus, adult, donor10258	10374-105G5	17.93	10.95	22.91
hippocampus, newborn, donor10223	10363-105F3	37.72	15.86	16.21
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.06	34.18	49.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	56.35	21.01	43.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	50.78	22.09	52.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	72.74	16.92	28.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	70.23	25.30	28.92
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	100.98	30.75	32.27
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	60.73	23.65	26.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.45	20.68	29.73
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	53.39	19.60	34.62
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	103.72	43.33	32.20
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	69.75	27.32	31.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	98.98	43.76	25.59
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	45.54	16.90	38.18
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.53	21.13	35.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	100.37	37.53	46.26
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	87.63	29.78	27.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.54	28.34	25.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	73.96	38.98	20.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	77.24	18.46	25.43
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.20	17.73	24.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	53.88	15.35	26.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.46	25.80	23.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	61.84	21.19	17.42
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.83	14.65	14.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	56.16	19.95	41.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	45.36	17.97	38.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	71.05	31.03	46.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	64.78	27.46	25.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	70.32	21.86	24.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	80.50	28.14	26.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.30	17.07	23.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	66.42	21.92	22.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.07	13.85	19.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.90	24.80	22.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	65.12	15.90	34.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	51.08	20.50	22.18
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	54.82	21.74	44.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	65.51	20.05	38.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	52.20	22.93	35.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	84.04	26.89	26.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	426.17	302.55	130.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	136.68	47.99	28.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	66.77	16.97	30.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	61.52	22.07	19.18
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	58.72	21.35	22.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	72.80	19.09	21.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	113.62	42.12	33.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.95	18.05	24.78
immature langerhans cells, donor1	11904-125F5	44.80	20.58	11.14
immature langerhans cells, donor2	11905-125F6	35.65	10.30	7.92
insula, adult, pool1	10039-101F3	105.42	26.78	21.95
keratoacanthoma cell line:HKA-1	10791-110H8	37.39	19.18	6.83
kidney, adult, pool1	10017-101C8	49.16	19.02	10.41
kidney, fetal, pool1	10045-101F9	36.85	6.65	10.33
large cell lung carcinoma cell line:IA-LM	10509-107D5	90.33	28.26	27.98
large cell lung carcinoma cell line:NCI-H460	10839-111E2	58.89	22.67	19.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.67	10.64	28.26
left atrium, adult, donor1	10079-102A7	21.25	5.45	9.26
left ventricle, adult, donor1	10078-102A6	16.69	7.58	12.64
leiomyoblastoma cell line:G-402	10721-110A1	75.79	42.96	29.28
leiomyoma cell line:10964C	10569-108B2	23.71	4.31	2.87
leiomyoma cell line:15242A	10570-108B3	43.48	10.33	4.89
leiomyoma cell line:15425	10571-108B4	53.66	17.97	7.77
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	10.46	13.59
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	77.21	34.35	36.95
liposarcoma cell line:KMLS-1	10782-110G8	39.99	18.12	5.15
liposarcoma cell line:SW 872	10726-110A6	20.47	13.65	14.86
liver, adult, pool1	10018-101C9	38.73	21.39	11.34
liver, fetal, pool1	10086-102B5	10.35	3.76	8.47
locus coeruleus - adult, donor10196	10182-103D2	26.83	4.96	22.60
locus coeruleus, adult, donor10252	10165-103B3	30.08	8.86	23.44
locus coeruleus, adult, donor10258	10375-105G6	24.55	8.75	21.16
locus coeruleus, newborn, donor10223	10362-105F2	55.10	21.03	18.09
lung adenocarcinoma cell line:A549	10499-107C4	54.39	15.64	10.66
lung adenocarcinoma cell line:PC-14	10408-106B3	64.11	25.51	6.89
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	61.95	29.53	14.37
lung, adult, pool1	10019-101D1	34.73	11.10	3.90
lung, fetal, donor1	10068-101I5	67.36	17.98	15.13
lung, right lower lobe, adult, donor1	10075-102A3	21.54	5.96	6.87
lymph node, adult, donor1	10077-102A5	36.45	12.78	7.57
lymphangiectasia cell line:DS-1	10727-110A7	53.70	18.85	11.18
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	119.84	60.97	28.37
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.00	17.84	13.59
mature adipocyte, donor1	12231-129F8	29.75	6.66	4.88
mature adipocyte, donor2	12232-129F9	29.26	10.58	4.77
mature adipocyte, donor3	12233-129G1	41.49	12.33	4.03
mature adipocyte, donor4	12234-129G2	56.59	17.64	8.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	148.91	48.84	21.44
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	23.69	25.94
medial frontal gyrus, adult, donor10252	10150-102I6	56.28	16.92	17.29
medial frontal gyrus, adult, donor10258	10368-105F8	53.37	16.84	21.92
medial frontal gyrus, newborn, donor10223	10352-105E1	95.53	32.41	18.77
medial temporal gyrus - adult, donor10196	10183-103D3	85.56	27.84	20.42
medial temporal gyrus, adult, donor10252	10156-103A3	51.15	13.16	16.77
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	11.56	26.97
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	760.74	330.13	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	52.76	10.77	22.25
medulla oblongata - adult, donor10196	10174-103C3	13.63	10.38	9.09
medulla oblongata, adult, donor10252	10155-103A2	33.13	10.68	12.85
medulla oblongata, adult, pool1	10038-101F2	39.92	8.49	13.71
medulla oblongata, newborn, donor10223	10361-105F1	24.65	9.03	11.11
medulloblastoma cell line:D283 Med	10838-111E1	149.01	38.08	42.29
medulloblastoma cell line:ONS-76	10759-110E3	42.31	20.05	24.45
melanoma cell line:COLO 679	10514-107E1	54.48	25.44	11.50
melanoma cell line:G-361	10465-106H6	69.22	23.07	14.39
meningioma cell line:HKBMM	10691-109F7	39.26	10.31	11.04
merkel cell carcinoma cell line:MKL-1	10843-111E6	76.66	54.63	31.72
merkel cell carcinoma cell line:MS-1	10844-111E7	77.51	30.85	45.88
mesenchymal precursor cell - adipose, donor1	11747-123G1	76.72	33.45	8.75
mesenchymal precursor cell - adipose, donor2	11748-123G2	50.90	22.00	4.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	57.15	14.08	4.97
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.79	19.95	5.76
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	12.13	7.13
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	13.88	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	39.65	13.22	8.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.84	13.46	7.36
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.18	20.43	4.64
mesenchymal precursor cell - cardiac, donor4	11755-123G9	57.66	23.09	8.91
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	41.40	19.21	9.82
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.38	9.22	4.61
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.30	18.40	6.50
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.10	13.96	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.32	14.50	7.55
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.48	4.67	5.39
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.48	7.14	4.55
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.10	7.75	7.98
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	75.10	32.31	15.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	34.52	17.78	4.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.43	15.23	10.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	27.61	11.04	7.36
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	26.33	9.16	7.44
mesenchymal stem cell line:Hu5/E18	10568-108B1	73.26	24.00	9.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.01	11.42	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.62	11.77	3.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.81	9.95	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.65	7.70	4.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.01	10.36	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.72	10.83	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.01	9.04	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	35.22	9.27	3.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.26	11.25	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.78	8.48	3.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.05	10.82	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	8.80	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.89	8.39	4.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.79	8.19	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.79	7.73	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	15.49	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.91	10.07	4.22
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	13.09	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.86	10.13	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	13.08	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.10	7.39	6.61
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	8.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	10.93	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	14.30	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	9.49	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	7.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	12.67	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	12.76	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	4.30	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	28.52	6.52	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	37.34	7.94	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	6.48	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.74	5.30	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	43.76	13.01	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	7.70	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	37.86	18.59	9.64
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	17.81	7.42
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	13.46	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	45.16	15.90	7.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	12.90	7.25
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	8.72	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	10.14	11.40
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.99	6.68	12.74
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	9.04	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	31.30	6.59	10.71
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.33	12.70	4.76
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.87	8.11	4.87
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	9.17	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	4.64	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	68.75	17.25	18.66
mesothelioma cell line:ACC-MESO-4	10494-107B8	52.59	24.79	11.12
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	102.57	17.09	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	59.70	24.25	8.01
mesothelioma cell line:Mero-25	10850-111F4	34.04	12.48	21.56
mesothelioma cell line:Mero-41	10851-111F5	74.56	27.14	17.60
mesothelioma cell line:Mero-48a	10852-111F6	59.12	27.46	17.94
mesothelioma cell line:Mero-82	10853-111F7	57.29	22.08	22.08
mesothelioma cell line:Mero-83	10854-111F8	61.28	23.66	13.62
mesothelioma cell line:Mero-84	10855-111F9	38.93	14.91	19.21
mesothelioma cell line:Mero-95	10856-111G1	57.76	23.19	12.22
mesothelioma cell line:NCI-H2052	10847-111F1	73.55	29.98	16.56
mesothelioma cell line:NCI-H226	10846-111E9	89.23	41.99	19.19
mesothelioma cell line:NCI-H2452	10848-111F2	84.04	39.63	12.30
mesothelioma cell line:NCI-H28	10845-111E8	92.63	33.59	32.57
mesothelioma cell line:No36	10857-111G2	42.08	20.55	15.01
mesothelioma cell line:ONE58	10858-111G3	73.97	24.66	14.09
migratory langerhans cells, donor1	11901-125F2	49.90	18.62	5.37
migratory langerhans cells, donor2	11902-125F3	25.03	13.43	2.32
migratory langerhans cells, donor3	11903-125F4	38.77	19.38	5.92
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.30	8.49	20.24
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.47	8.69	14.20
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	75.10	26.26	46.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	41.86	24.36	6.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	184.79	49.15	25.87
myeloma cell line:PCM6	10474-106I6	44.67	9.88	5.14
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	8.62	15.73
myxofibrosarcoma cell line:NMFH-1	10684-109E9	44.33	16.87	7.65
nasal epithelial cells, donor1, tech_rep1	12226-129F3	65.85	14.93	29.86
nasal epithelial cells, donor1, tech_rep2	12226-129F3	68.91	17.50	29.27
nasal epithelial cells, donor2	12227-129F4	72.31	11.59	16.01
neuroblastoma cell line:CHP-134	10508-107D4	173.24	54.06	41.64
neuroblastoma cell line:NB-1	10539-107G8	106.08	47.71	39.10
neuroblastoma cell line:NBsusSR	10607-108F4	65.59	37.33	36.27
neuroblastoma cell line:NH-12	10555-107I6	174.61	44.91	38.57
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	102.72	19.45	14.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	58.76	25.82	9.50
neuroectodermal tumor cell line:TASK1	10774-110F9	132.63	46.29	33.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	18.44	20.98
neurofibroma cell line:Hs 53.T	10729-110A9	22.09	11.98	8.78
neutrophil PMN, donor1	12133-128D9	14.87	0.00	29.75
neutrophil PMN, donor2	12137-128E4	26.56	0.00	13.28
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	131.91	57.84	25.54
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	58.44	32.02	60.04
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.87	9.94	7.37
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.36	12.61	7.09
nucleus accumbens, adult, pool1	10037-101F1	93.93	27.93	18.47
occipital cortex - adult, donor10196	10172-103C1	35.03	20.60	12.36
occipital cortex, adult, donor10252	10163-103B1	50.99	9.12	16.64
occipital cortex, newborn, donor10223	10355-105E4	85.53	19.29	19.29
occipital lobe, adult, donor1	10076-102A4	67.70	22.83	25.45
occipital lobe, fetal, donor1	10073-102A1	64.37	15.02	57.93
occipital pole, adult, pool1	10036-101E9	43.91	10.56	11.43
olfactory region, adult	10195-103E6	53.69	9.36	16.81
optic nerve, donor1	10277-104E7	26.01	8.00	18.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	131.56	41.92	39.64
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	142.88	50.42	49.87
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	39.28	11.01	11.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	64.80	32.34	24.26
osteoclastoma cell line:Hs 706.T	10704-109H2	32.92	7.94	8.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	99.04	25.23	13.08
osteosarcoma cell line:HS-Os-1	10558-107I9	67.86	39.23	20.15
ovary, adult, pool1	10020-101D2	25.86	7.86	12.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.30	6.23	11.55
pancreas, adult, donor1	10049-101G4	50.79	12.23	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.93	15.65	18.17
papillary adenocarcinoma cell line:8505C	10437-106E5	64.22	21.12	14.14
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.93	19.37	14.07
paracentral gyrus, adult, pool1	10035-101E8	100.13	25.99	22.51
parietal cortex, adult, donor10258	10373-105G4	65.33	13.21	14.68
parietal lobe - adult, donor10196	10171-103B9	38.56	15.99	26.33
parietal lobe, adult, donor10252	10157-103A4	58.15	13.68	20.24
parietal lobe, adult, pool1	10034-101E7	83.63	21.06	19.56
parietal lobe, fetal, donor1	10072-101I9	74.68	22.31	64.01
parietal lobe, newborn, donor10223	10356-105E5	66.55	11.96	20.56
parotid gland, adult	10199-103F1	27.75	7.40	6.78
penis, adult	10200-103F2	30.62	6.45	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	94.46	20.45	20.45
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.11	14.86	15.30
pineal gland - adult, donor10196	10179-103C8	13.55	4.52	18.71
pineal gland, adult, donor10252	10160-103A7	59.22	24.28	24.28
pineal gland, adult, donor10258	10377-105G8	23.83	8.15	13.80
pituitary gland - adult, donor10196	10180-103C9	45.53	13.15	24.28
pituitary gland, adult, donor10252	10162-103A9	63.58	28.14	41.69
pituitary gland, adult, donor10258	10378-105G9	45.12	17.88	21.28
placenta, adult, pool1	10021-101D3	29.99	13.87	5.48
plasma cell leukemia cell line:ARH-77	10840-111E3	61.71	22.64	16.82
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	50.27	27.39	10.43
pons, adult, pool1	10033-101E6	87.01	21.78	28.66
postcentral gyrus, adult, pool1	10032-101E5	65.12	16.21	13.43
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	6.27	16.73
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	53.89	20.68	19.52
prostate cancer cell line:PC-3	10439-106E7	87.67	41.02	33.58
prostate, adult, pool1	10022-101D4	42.44	11.06	6.62
putamen, adult, donor10196	10176-103C5	72.47	35.41	8.26
putamen, adult, donor10252	10152-102I8	49.02	19.61	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	12.02	19.67
putamen, adult, donor10258, tech_rep2	10372-105G3	55.33	30.68	11.84
putamen, newborn, donor10223	10365-105F5	61.47	28.49	14.24
rectal cancer cell line:TT1TKB	10469-106I1	100.08	19.49	24.15
rectum, fetal, donor1	10067-101I4	41.73	12.52	11.13
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.59	35.19	13.78
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	82.01	14.91	11.18
retina, adult, pool1	10030-101E3	34.59	8.65	10.74
retinoblastoma cell line:Y79	10475-106I7	208.88	62.09	58.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.11	21.52	12.42
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	104.33	53.71	45.55
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	4.55	12.13
salivary acinar cells, donor1	11771-123I7	81.09	17.97	9.71
salivary acinar cells, donor2	11772-123I8	53.97	10.88	4.68
salivary acinar cells, donor3	11773-123I9	15.23	1.99	6.62
salivary gland, adult, pool1	10093-102C3	52.62	7.44	6.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	55.73	11.13	9.95
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	47.14	9.87	10.81
seminal vesicle, adult	10201-103F3	25.40	5.29	6.35
serous adenocarcinoma cell line:JHOS-2	10639-108I9	74.09	36.92	14.82
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	50.07	17.87	29.19
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	77.27	37.13	23.08
serous cystadenocarcinoma cell line:HTOA	10693-109F9	77.77	24.45	11.42
signet ring carcinoma cell line:Kato III	10436-106E4	160.60	43.11	25.42
signet ring carcinoma cell line:NUGC-4	10483-107A6	151.48	50.71	18.19
skeletal muscle - soleus muscle, donor1	10282-104F3	30.50	4.97	24.83
skeletal muscle, adult, pool1	10023-101D5	63.33	15.47	14.03
skeletal muscle, fetal, donor1	10066-101I3	49.25	12.06	20.10
skin, adult, donor1	10074-102A2	20.36	6.79	0.00
skin, fetal, donor1	10065-101I2	49.87	14.52	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.68	19.68	34.02
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	119.78	57.05	78.17
small cell lung carcinoma cell line:DMS 144	10841-111E4	50.31	11.56	25.64
small cell lung carcinoma cell line:LK-2	10541-107H1	206.03	58.51	62.30
small cell lung carcinoma cell line:NCI-H82	10842-111E5	193.02	29.44	103.59
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.17	25.50	39.01
small intestine, adult, pool1	10024-101D6	58.53	16.72	8.48
small intestine, fetal, donor1	10064-101I1	51.35	12.78	12.78
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	68.22	30.77	11.28
smooth muscle, adult, pool1	10048-101G3	26.36	6.20	9.05
somatostatinoma cell line:QGP-1	10781-110G7	55.21	17.96	21.71
spinal cord - adult, donor10196	10181-103D1	30.05	5.05	18.12
spinal cord, adult, donor10252	10159-103A6	39.03	11.43	13.80
spinal cord, adult, donor10258	10369-105F9	9.69	2.77	14.53
spinal cord, fetal, donor1	10056-101H2	30.49	13.42	21.95
spinal cord, newborn, donor10223	10359-105E8	37.66	13.32	14.24
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.16	11.35	6.42
spleen, adult, pool1	10025-101D7	31.06	12.78	6.28
spleen, fetal, pool1	10044-101F8	18.20	6.75	5.09
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	87.67	38.40	13.77
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.76	28.48	17.47
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.29	8.74	8.74
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.09	7.43	30.10
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.53	10.24	24.88
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	61.85	41.09	31.35
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	37.23	26.23	9.73
stomach, fetal, donor1	10062-101H8	25.63	9.61	10.68
submaxillary gland, adult	10202-103F4	23.93	4.56	8.55
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	28.04	8.10	12.88
substantia nigra, adult, donor10258	10371-105G2	8.79	4.14	20.69
substantia nigra, newborn, donor10223	10358-105E7	31.09	7.07	16.96
synovial sarcoma cell line:HS-SY-II	10441-106E9	68.09	35.54	18.11
temporal lobe, adult, pool1	10031-101E4	48.83	13.14	13.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	52.00	13.53	42.02
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	46.59	12.75	36.04
tenocyte, donor1	11763-123H8	30.72	10.12	6.28
tenocyte, donor2	11765-123I1	29.76	4.96	3.82
tenocyte, donor3	11768-123I4	29.28	12.23	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	103.34	37.22	75.97
teratocarcinoma cell line:NCR-G1	10798-110I6	54.11	22.04	31.60
teratocarcinoma cell line:PA-1	10807-111A6	98.41	32.70	45.41
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.79	16.12	14.35
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	168.66	52.19	47.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	77.22	23.99	14.18
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	66.12	17.26	31.92
testis, adult, pool1	10026-101D8	32.53	8.91	24.70
testis, adult, pool2	10096-102C6	16.69	4.51	37.89
thalamus - adult, donor10196	10168-103B6	19.87	8.83	14.35
thalamus, adult, donor10252	10154-103A1	36.57	11.56	13.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	4.62	27.71
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.02	8.73	19.93
thalamus, newborn, donor10223	10366-105F6	45.45	13.81	17.83
throat, adult	10209-103G2	32.96	10.24	9.49
throat, fetal, donor1	10061-101H7	37.17	9.75	14.63
thymic carcinoma cell line:Ty-82	10803-111A2	122.02	34.78	16.89
thymus, adult, pool1	10027-101D9	69.19	27.94	10.24
thymus, fetal, pool1	10043-101F7	64.94	23.69	10.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	67.94	29.78	16.09
thyroid carcinoma cell line:TCO-1	10783-110G9	64.96	16.62	19.70
thyroid, adult, pool1	10028-101E1	74.56	16.24	9.52
thyroid, fetal, donor1	10060-101H6	32.96	8.70	10.81
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	0.00
tongue, adult	10203-103F5	38.14	16.51	11.63
tongue, fetal, donor1	10059-101H5	35.86	11.82	12.61
tonsil, adult, pool1	10047-101G2	47.58	14.63	6.11
trachea, adult, pool1	10029-101E2	53.09	18.32	7.12
trachea, fetal, donor1	10058-101H4	30.01	8.08	6.16
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	44.64	19.13	10.63
transitional-cell carcinoma cell line:5637	10418-106C4	99.39	36.27	37.59
transitional-cell carcinoma cell line:JMSU1	10492-107B6	75.84	17.86	25.54
tridermal teratoma cell line:HGRT	10694-109G1	20.93	1.90	9.51
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	78.64	32.59	16.34
umbilical cord, fetal, donor1	10057-101H3	12.52	4.17	10.43
uterus, adult, pool1	10100-102D1	39.76	5.12	8.19
uterus, fetal, donor1	10055-101H1	37.88	11.77	8.70
vagina, adult	10204-103F6	23.91	4.52	4.52
vein, adult	10191-103E2	29.59	8.99	4.82
xeroderma pigentosum b cell line:XPL 17	10563-108A5	76.91	30.44	8.55